Upload
others
View
6
Download
0
Embed Size (px)
Citation preview
Health Sciences Authority Certificate No. : LA-2001-0210-A Applied Sciences Group (Part 2 of 3) Pharmaceutical Division 11 Outram Road Issue No. : 23 Singapore 169078 Date : 06 June 2019 Pharmaceutical Laboratory Page : 1 of 50 FIELD OF TESTING : Chemical & Biological Testing
MATERIALS / PRODUCTS TESTED
TESTS / PROPERTIES STANDARD METHODS /
TECHNIQUES / EQUIPMENT
A. INJECTION
1. Adrenaline Injection a. Identification British Pharmacopoeia (BP 2019)
b. Acidity
c. D-adrenaline HPLC
d. Assay HPLC
2. Amikacin Sulfate Injection a. Identification United States Pharmacopoeia 42
b. pH (USP42-NF37)
c. Assay HPLC
3. Aminophylline Injection a. Identification BP 2019
b. pH
c. Assay UV Spectrophotometry & Titrimetry
BP 2017
4. Amitriptyline Hydrochloride a. Identification USP41-NF36
Injection b. pH
c. Assay HPLC
5. Amoxycillin Injection a. Identification BP 2019
b. Water
c. Assay HPLC
6. Ampicillin Injection a. Identification BP 2019
b. pH
c. Related Substances HPLC
d. Water
e. Assay HPLC
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 2 of 50
MATERIALS / PRODUCTS TESTED TESTS / PROPERTIES STANDARD METHODS /
TECHNIQUES / EQUIPMENT
7. Anticoagulant Citrate a. Identification USP 28 / USP42-NF37 Phosphate Dextrose Solution b. pH c. Assay UV / Titrimetry / Gravimetry d. Chloride
8. Anticoagulant Citrate Phosphate a. Identification USP 28 / USP42-NF37 Dextrose Adenine Solution b. pH c. Assay UV / Titrimetry /Gravimetry / AAS / HPLC d. Chloride
9. Ascorbic Acid Injection a. Identification USP42-NF37 b. pH c. Assay HPLC
10. Atropine Injection a. Identification BP 2019 b. Acidity c. Assay HPLC
11. Bethanechol Chloride Injection a. Identification USP42-NF37 b. Assay HPLC
12. Benztropine Injection a. Identification USP42-NF37 b. Acidity or alkalinity c. Assay HPLC
13. Benzylpenicillin Injection a. Identification BP 2019 b. Acidity or alkalinity c. Loss on drying d. Assay HPLC 14. Betamethasone Sodium a. Identification USP42-NF37 Phosphate Injection b. pH c. Assay HPLC
15. Bupivacaine Injection a. Identification BP 2019 b. Acidity c. 2,6-Dimethylamine d. Assay HPLC
16. Calcium Chloride Injection a. Identification USP42-NF37 b. pH c. Assay Titrimetry
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 3 of 50
MATERIALS / PRODUCTS TESTED TESTS / PROPERTIES STANDARD METHODS /
TECHNIQUES / EQUIPMENT
17. Calcium Gluconate Injection a. Identification USP42-NF37 b. pH c. Assay Titrimetry 18. Cefazoline Sodium, Sterile a. Identification USP42-NF37 b. pH c. Water d. Assay HPLC 19. Chloramphenicol Sodium a. Identification BP 2019 Succinate Injection b. pH c. Water d. Assay UV Spectrophotometry 20. Chlorpheniramine Injection a. Identification BP 2019 b. pH c. Assay UV Spectrophotometry d. Related substances TLC 21. Chlorpromazine Injection a. Identification BP 2019 b. pH c. Assay UV Spectrophotometry d. Related substances TLC 22. Cimetidine Injection a. Identification BP 2019 b. pH c. Assay UV Spectrophotometry 23. Ciprofloxacin Injection a. Identification USP42-NF37 b. pH c. Assay HPLC 24. Codeine Phosphate Injection a. Identification USP42-NF37 b. pH c. Assay Titrimetry 25. Cyclophosphamide Injection a. Identification BP 2019 / USP42-NF37 b. pH c. Assay HPLC (USP42-NF37) 26. Cytarabine Injection a. Identification BP 2019 / USP42-NF37 b. pH c. Assay HPLC d. Water
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 4 of 50
MATERIALS / PRODUCTS TESTED TESTS / PROPERTIES STANDARD METHODS /
TECHNIQUES / EQUIPMENT
27. Daunorubicin Hydrochloride for a. Identification USP42-NF37 Injection b. pH c. Assay HPLC d. Water 28. Dexamethasone Sodium a. Identification USP42-NF37 Phosphate Injection b. pH c. Assay HPLC 29. Dextran 40 Intravenous Infusion a. Identification BP 2019 b. pH c. Glucose content Titrimetry d. Assay Optical Rotation 30. Dextrose Injection a. Identification USP42-NF37 b. pH c. 5-Hydroxymethylfurfural UV Spectrophotometry and related substances d. Assay Optical Rotation e. Heavy metals 31. Diazepam Injection a. Identification BP 2019 / USP42-NF37 b. pH c. Assay UV Spectrophotometry / HPLC 32. Diazoxide Injection a. Identification BP 2019 b. pH c. Assay UV Spectrophotometry 33. Dibucaine Hydrochloride a. Identification USP42-NF37 Injection b. pH c. Assay HPLC 34. Digoxin Injection / Digoxin a. Identification BP 2019 Injection, Paediatric b. pH c. Assay UV Spectrophotometry 35. Dimenhydrinate Injection a. pH USP42-NF37 b. Assay HPLC 36. Dobutamine Hydrochloride for a. Identification USP42-NF37 Injection b. pH
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 5 of 50
MATERIALS / PRODUCTS TESTED TESTS / PROPERTIES STANDARD METHODS /
TECHNIQUES / EQUIPMENT
37. Dopamine Hydrochloride Injection a. Identification USP42-NF37 b. pH c. Assay HPLC 38. Doxorubicin Hydrochloride for a. Identification USP42-NF37 Injection/Doxorubicin b. pH Hydrochloride Injection c. Assay HPLC d. Water 39. Droperidol Injection a. Identification USP42-NF37 b. pH c. Assay HPLC 40. Ephedrine Sulfate Injection a. Identification USP42-NF37 b. pH c. Assay Titrimetry 41. Ergometrine Injection a. Identification BP 2019 b. pH c. Assay UV Spectrophotometry d. Related substances TLC 42. Erythromycin Lactobionate a. Identification BP 2019 Intravenous Infusion b. pH 43. Fluorouracil Injection a. Identification BP 2019 b. pH c. Related substances TLC d. Assay UV Spectrophotometry 44. Fluphenazine Decanoate a. Identification BP 2019 Injection b. Related substances HPLC c. Assay Titrimetry 45. Folic Acid Injection a. Identification USP42-NF37 b. pH c. Assay HPLC 46. Fructose Intravenous Infusion a. Identification BP 2015 b. pH c. 5-Hyroxymethylfurfural and UV Spectrophotometry related substances d. Assay Optical Rotation
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 6 of 50
MATERIALS / PRODUCTS TESTED TESTS / PROPERTIES STANDARD METHODS /
TECHNIQUES / EQUIPMENT
47. Frusemide Injection a. Identification BP 2019 b. pH c. Related substances HPLC d. Assay UV Spectrophotometry 48. Furosemide Injection a. Identification USP42-NF37 b. pH c. Assay HPLC 49. Gentamicin Injection/ Gentamicin a. Identification BP 2019 Sulfate Injection b. pH 50. Glucose Intravenous Infusion a. Identification BP 2019 b. pH c. 5-Hyroxymethylfurfural UV Spectrophotometry and related substances d. Assay Optical Rotation 51. Glycine Irrigation Solution a. Identification BP 2019 b. pH c. Assay Titrimetry 52. Haemodialysis Solutions a. Identification BP 2019 b. Extractable volume c. Assay Titrimetry / AAS 53. Haloperidol Injection a. Identification BP 2019 b. pH c. Related substances TLC d. Assay UV Spectrophotometry 54. Hydralazine Injection a. Identification BP 2019 b. pH c. Assay Titrimetry 55. Hydrocortisone Sodium Succinate a. Identification BP 2019 injection b. pH c. Related substances HPLC d. Assay UV Spectrophotometry 56. Hydroxyprogesterone Caproate a. Identification USP42-NF37 Injection b. Assay HPLC
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 7 of 50
MATERIALS / PRODUCTS TESTED TESTS / PROPERTIES STANDARD METHODS /
TECHNIQUES / EQUIPMENT
57. Hydroxyzine Hydrochloride a. Identification USP42-NF37 Injection b. pH c. Assay HPLC 58. Hyoscine Butylbromide Injection a. Identification BP 2019 b. pH c. Assay HPLC 59. Iron Dextran Injection a. Identification BP 2019 b. pH c. Content of Dextrans UV Spectrophotometry d. Chloride Titrimetry 60. Isoniazid Injection a. Identification BP 2019 b. pH c. Assay Titrimetry 61. Isoprenaline Injection a. Identification BP 2019 b. pH c. Assay HPLC 62. Kanamycin Injection/ a. Identification USP42-NF37 Kanamycin Sulfate Injection b. pH 63. Ketamine Hydrochloride a. Identification USP42-NF37 Injection b. pH c. Assay UV Spectrophotometry 64. Labetalol Injection a. Identification BP 2019 b. pH c. Assay UV Spectrophotometry 65. Lactated Ringer’s Injection a. Identification USP42-NF37 b. pH c. Heavy Metals USP37-NF32 d. Assay for calcium, potassium, AAS / Titrimetry / HPLC sodium, chloride and lactate 66. Leucovorin Calcium Injection a. Identification USP42-NF37 b. pH c. Assay HPLC 67. Lidocaine Hydrochloride a. Identification BP 2019 / USP42-NF37 Injection/Lignocaine Injection b. pH c. Assay Titrimetry / HPLC
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 8 of 50
MATERIALS / PRODUCTS TESTED TESTS / PROPERTIES STANDARD METHODS /
TECHNIQUES / EQUIPMENT
68. Lidocaine & Epinephrine Injection a. Identification BP 2019 / USP42-NF37 / Lignocaine & Adrenaline Injection b. pH c. Assay HPLC 69. Lincomycin Hydrochloride Injection a. Identification USP42-NF37 b. pH c. Assay HPLC 70. Magnesium Sulfate Injection a. Identification BP 2019 / USP42-NF37 b. pH c. Assay Titrimetry 71. Mannitol Injection a. Identification BP 2019 / USP42-NF37 / Mannitol Intravenous Infusion b. pH c. Assay Titrimetry / HPLC 72. Methotrexate Injection a. Identification USP42-NF37 b. pH c. Assay HPLC 73. Methylene Blue Injection a. Identification USP42-NF37 b. pH c. Assay UV Spectrophotometry 74. Metoclopramide Injection a. Identification BP 2019 b. pH c. Related substances HPLC d. Assay HPLC 75. Metronidazole Injection a. Identification USP42-NF37 b. pH c. Assay HPLC 76. Miconazole Injection a. Identification USP42-NF37 b. pH c. Assay HPLC 77. Morphine Sulfate Injection a. Identification BP 2019 b. Assay HPLC 78. Naloxone Hydrochloride Injection a. Identification USP42-NF37 b. pH c. Assay HPLC
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 9 of 50
MATERIALS / PRODUCTS TESTED TESTS / PROPERTIES STANDARD METHODS /
TECHNIQUES / EQUIPMENT
79. Nandrolone Decanoate Injection a. Identification BP 2019 b. Assay UV Spectrophotometry 80. Neostigmine Injection a. Identification BP 2019 b. pH c. Assay UV Spectrophotometry 81. Nitroglycerin Injection a. Identification USP42-NF37 b. pH c. Assay HPLC 82. Pancuronium Injection a. Identification BP 2019 b. pH c. Assay UV Spectrophotometry 83. Papaverine Hydrochloride Injection a. Identification USP42-NF37 b. pH c. Assay UV Spectrophotometry 84. Penicillin G Potassium Injection a. Identification USP42-NF37 b. pH c. Assay HPLC 85. Pentazocine Injection a. Identification BP 2019 b. pH c. Related substances TLC d. Assay UV Spectrophotometry 86. Pethidine Injection a. Identification BP 2019 b. Related Substances HPLC c. Assay HPLC 87. Phenobarbital Injection a. Identification BP 2019 b. pH c. Assay HPLC 88. Phenylephrine Injection a. Identification BP 2019 b. pH c. Related substances TLC (BP 2017) d. Assay UV Spectrophotometry 89. Phenytoin Injection a. Identification BP 2019 / USP42-NF37 / Phenytoin Sodium Injection b. pH c. Assay Gravimetry / HPLC
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 10 of 50
MATERIALS / PRODUCTS TESTED TESTS / PROPERTIES STANDARD METHODS /
TECHNIQUES / EQUIPMENT
90. Phytomenadione Injection a. Identification BP 2019 b. pH 91. Physostigmine Salicylate Injection a. Identification USP42-NF37 b. pH c. Assay HPLC 92. Potassium Chloride & Sodium a. Identification BP 2019 Chloride Intravenous Infusion b. Assay Atomic Emission Spectrophotometry 93. Potassium Chloride Injection a. Identification USP42-NF37 b. pH c. Assay Atomic Emission Spectrophotometry 94. Prednisolone acetate injectable a. Identification USP42-NF37 Suspension (Sterile suspension) b. Assay HPLC 95. Procainamide Injection a. Identification BP 2019 b. pH c. Related substances TLC d. Assay Titrimetry 96. Prochlorperazine Injection a. Identification BP 2019 b. pH c. Related substances TLC d. Assay UV Spectrophotometry 97. Progesterone Injection a. Identification BP 2019 b. Assay BP2014 - UV Spectrophotometry 98. Promazine Injection a. Identification BP 2019 b. pH c. Related substances TLC d. Assay UV Spectrophotometry 99. Promethazine Injection a. Identification BP 2019 b. pH c. Related substances TLC d. Assay UV Spectrophotometry 100. Propranolol Injection a. Identification BP 2019 b. pH c. Related substances HPLC d. Assay UV Spectrophotometry
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 11 of 50
MATERIALS / PRODUCTS TESTED TESTS / PROPERTIES STANDARD METHODS /
TECHNIQUES / EQUIPMENT
101. Ringer’s Injection a. Identification USP42-NF37 b. pH c. Heavy Metals USP37-NF32 d. Assay for calcium, potassium, AAS & Titrimetry sodium & chloride 102. Salbutamol Injection a. Identification BP 2019 b. Assay HPLC 103. Sodium Bicarbonate Intravenous a. Identification BP 2019 Infusion b. Assay Titrimetry 104. Sodium Chloride Intravenous a. Identification BP 2019 Infusion b. Assay Titrimetry 105. Sodium Chloride & Glucose a. Identification BP 2019 Intravenous Infusion b. pH c. Assay for sodium chloride & Titrimetry d. Glucose Optical Rotation e. Related substances UV Spectrophotometry 106. Iothalamate Sodium Injection a. Identification USP 40-NF35 b. pH c. Assay Titrimetry 107. Sodium Lactate Intravenous a. Identification BP 2019 Infusion, Compound b. pH c. Assay for sodium, potassium, Atomic Emission chloride & lactate Spectrophotometry, Titrimetry & HPLC 108. Sulfamethoxazole & Trimethoprim a. Identification USP42-NF37 Injection b. pH c. Assay HPLC 109. Suxamethonium Chloride a. Identification BP 2019 Injection b. pH c. Hydrolysis product Titrimetry d. Assay Titrimetry 110. Terbutaline Sulfate Injection a. Identification USP42-NF37 b. pH c. Assay HPLC
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 12 of 50
MATERIALS / PRODUCTS TESTED TESTS / PROPERTIES STANDARD METHODS /
TECHNIQUES / EQUIPMENT
111. Thiamine Injection a. Identification BP 2019 b. pH c. Assay HPLC 112. Thiopental Injection a. Identification BP 2019 b. pH c. Related substances BP 2014 - TLC d. Assay Titrimetry & Gravimetry e. Clarity & color of solution f. Loss on drying 113. Triamcinolone Acetonide Injection a. Identification BP 2019 b. pH c. Assay HPLC 114. Triamcinolone Acetonide a. Identification USP42-NF37 Injectable Suspension b. Assay HPLC (Sterile Suspension) 115. Verapamil Injection a. Identification BP 2019 b. pH c. Related substances HPLC d. Assay UV Spectrophotometry 116. Vincristine Injection a. Identification BP 2019 b. Clarity of solution c. Related alkaloids HPLC d. Assay UV Spectrophotometry 117. Water, Purified/Injection a. Acidity or alkalinity BP 2019 b. Ammonium c. Calcium & magnesium d. Heavy metals e. Chloride f. Sulphate g. Oxidisable substances h. Residue on evaporation i. Aluminium
B. TABLETS 1. Acetaminophen and codeine a. Identification USP42-NF37 phosphate tablets b. Assay HPLC
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 13 of 50
MATERIALS / PRODUCTS TESTED TESTS / PROPERTIES STANDARD METHODS /
TECHNIQUES / EQUIPMENT
2. Acetaminophen tablets a. Identification USP42-NF37 b. Assay HPLC 3. Acetaminophen and a. Identification USP42-NF37 caffeine tablets b. Assay HPLC 4. Acetazolamide tablets a. Identification USP42-NF37 b. Assay HPLC 5. Acyclovir tablets a. Identification BP 2019 b. Assay BP2014 - UV Spectrophotometry 6. Allopurinol tablets a. Identification BP 2019 b. Assay UV Spectrophotometry c. Related substances HPLC 7. Amiloride hydrochloride and a. Identification USP42-NF37 Hydrochlorothiazide tablets b. Assay HPLC 8. Amitriptyline tablets a. Identification BP 2019 b. Assay HPLC 9. Benzhexol tablets a. Identification BP 2019 b. Assay HPLC 10. Betamethasone tablets a. Identification BP 2019 b. Assay HPLC 11. Bromocriptine mesylate tablets a. Identification USP42-NF37 b. Assay HPLC 12. Calcium carbonate tablets a. Identification USP42-NF37 b. Assay Titrimetry 13. Captopril tablets a. Identification USP42-NF37 b. Assay HPLC c. Related compounds HPLC 14. Carbamazepine tablets a. Identification BP 2019 b. Assay HPLC 15. Dapsone tablets a. Identification BP 2019 b. Assay Titrimetry
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 14 of 50
MATERIALS / PRODUCTS TESTED TESTS / PROPERTIES STANDARD METHODS /
TECHNIQUES / EQUIPMENT
16. Dexamethasone tablets a. Identification BP 2019 / USP42-NF37 b. Assay HPLC 17. Diazepam tablets a. Identification BP 2019 / USP42-NF37 b. Assay UV Spectrophotometry / HPLC 18. Diltiazem hydrochloride tablets a. Identification USP42-NF37 b. Assay HPLC 19. Enalapril maleate tablets a. Identification USP42-NF37 b. Assay HPLC 20. Ephedrine hydrochloride tablets a. Identification BP 2019 b. Assay HPLC 21. Erythromycin tablets a. Identification USP42-NF37 22. Ergotamine tartrate and a. Identification USP42-NF37 caffeine tablets b. Assay HPLC 23. Famotidine tablets a. Identification USP42-NF37 b. Assay HPLC 24. Ferrous fumarate tablets a. Identification BP 2019 b. Assay Titrimetry c. Ferric iron Titrimetry 25. Fludrocortisone tablets a. Identification BP 2019 b. Assay HPLC 26. Glibenclamide tablets a. Identification BP 2019 b. Assay HPLC 27. Glipizide tablets a. Identification BP 2019 b. Assay UV Spectrophotometry 28. Griseofulvin tablets a. Identification BP 2019 b. Assay UV Spectrophotometry 29. Haloperidol tablets a. Identification BP 2019 / USP42-NF37 b. Assay HPLC c. Uniformity of content / HPLC / d. Uniformity of dosage units UV e. Related substances
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 15 of 50
MATERIALS / PRODUCTS TESTED TESTS / PROPERTIES STANDARD METHODS /
TECHNIQUES / EQUIPMENT
30. Hydralazine tablets a. Identification USP42-NF37 b. Assay HPLC c. Uniformity of dosage units d. Dissolution UV Spectrophotometry 31. Hydrochlorothiazide tablets a. Identification BP 2019 b. Assay UV Spectrophotometry c. Related substances HPLC 32. Hydrocortisone tablets a. Identification USP42-NF37 b. Assay HPLC c. Dissolution UV Spectrophotometry d. Uniformity of dosage units HPLC 33. Hydroxyzine hydrochloride tablets a. Identification USP42-NF37 b. Assay HPLC 34. Hyoscine butylbromide tablets a. Identification BP 2019 b. Assay HPLC c. Related substances TLC (BP 2017) 35. Hyoscine (Hydrobromide) tablets a. Identification BP 2019 b. Assay HPLC 36. Ibuprofen tablets a. Identification BP 2019 b. Assay HPLC 37. Imipramine tablets a. Identification BP 2019 / USP42-NF37 b. Assay UV Spectrophotometry c. Related substances TLC (BP 2019) d. Dissolution UV Spectrophotometry (USP42-NF37) e. Uniformity of dosage units UV Spectrophotometry (USP42-NF37) 38. Indapamide tablets a. Identification USP42-NF37 b. Assay HPLC 39. Iopanoic acid tablets a. Identification BP2017 b. Assay Titrimetry 40. Isoniazid tablets a. Identification BP 2019 b. Assay Titrimetry c. Dissolution UV Spectrophotometry
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 16 of 50
MATERIALS / PRODUCTS TESTED TESTS / PROPERTIES STANDARD METHODS /
TECHNIQUES / EQUIPMENT
41. Isosorbide dinitrate tablets a. Identification USP42-NF37 b. Assay HPLC c. Dissolution HPLC 42. Isoxsuprine tablets a. Identification USP42-NF37 b. Assay HPLC c. Dissolution UV Spectrophotometry 43. Ketoconazole tablets a. Identification USP42-NF37 b. Assay HPLC 44. Labetalol tablets a. Identification BP 2019 b. Assay UV Spectrophotometry 45. Levodopa tablets a. Identification BP 2019 b. Assay Titrimetry 46. Lithium carbonate tablets a. Identification BP 2019 b. Assay Titrimetry 47. Lorazepam tablets a. Identification BP 2018 / USP42-NF37 b. Assay UV Spectrophotometry/ HPLC 48. Compound Magnesium a. Assay BP 2019 - Titrimetry Trisilicate tablets 49. Mebendazole tablets a. Identification USP42-NF37 b. Assay HPLC 50. Medroxyprogesterone acetate a. Identification USP42-NF37 tablets b. Assay HPLC 51. Megestrol Acetate tablets a. Identification USP42-NF37 b. Assay HPLC 52. Metformin tablets a. Identification BP 2019 b. Assay UV Spectrophotometry c. Related substances HPLC d. Dissolution UV Spectrophotometry 53. Methyldopa tablets a. Identification BP 2019 b. Assay UV Spectrophotometry c. Optical rotation
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 17 of 50
MATERIALS / PRODUCTS TESTED TESTS / PROPERTIES STANDARD METHODS /
TECHNIQUES / EQUIPMENT
54. Metoclopramide tablets a. Identification BP 2019 b. Assay HPLC c. Related substances HPLC 55. Metronidazole tablets a. Identification BP 2019 b. Assay Titrimetry 56. Metoprolol tartrate tablets a. Identification USP42-NF37 b. Assay HPLC 57. Minoxidil tablets a. Identification USP42-NF37 b. Assay HPLC 58. Morphine tablets a. Identification BP 2019 b. Assay Titrimetry (BP 2017) 59. Nalidixic acid tablets a. Identification BP 2019 / USP42-NF37 b. Assay UV Spectrophotometry/ HPLC c. Dissolution UV Spectrophotometry 60. Naproxen tablets a. Identification BP 2019 b. Assay UV Spectrophotometry 61. Neostigmine tablets a. Identification BP 2019 b. Assay Titrimetry 62. Nicotinic acid tablets a. Identification BP 2019 b. Assay Titrimetry 63. Nitrazepam tablets a. Identification BP 2019 b. Assay UV Spectrophotometry (BP 2016) 64. Nitrofurantoin tablets a. Identification BP 2019 b. Assay UV Spectrophotometry 65. Norethisterone tablets a. Identification BP 2019 b. Assay HPLC 66. Norfloxacin tablets a. Identification USP42-NF37 b. Assay HPLC 67. Nortriptyline tablets a. Identification BP 2019 b. Assay HPLC
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 18 of 50
MATERIALS / PRODUCTS TESTED TESTS / PROPERTIES STANDARD METHODS /
TECHNIQUES / EQUIPMENT
68. Oxprenolol tablets a. Identification BP 2019 b. Assay UV Spectrophotometry 69. Phenobarbitone tablets a. Identification BP 2019 b. Assay HPLC c. Disintegration 70. Phenoxymethylpenicillin tablets a. Identification BP 2019 b. Assay UV Spectrophotometry c. Dissolution UV Spectrophotometry 71. Pimozide tablets a. Identification USP42-NF37 b. Assay HPLC 72. Pindolol tablets a. Identification BP 2019 b. Assay UV Spectrophotometry 73. Effervescent Potassium chloride a. Identification BP 2019 tablets b. Assay AAS/Titrimetry c. Disintegration 74. Slow Potassium chloride tablets a. Identification BP 2019 b. Assay Atomic Emission Spectrophotometry c. Dissolution Titrimetry 75. Prazosin tablets a. Identification BP 2019 b. Assay HPLC 76. Prednisolone tablets a. Identification BP 2019 b. Assay HPLC c. Related substances HPLC d. Dissolution HPLC 77. Prednisone tablets a. Identification USP42-NF37 b. Assay HPLC 78. Primidone tablets a. Identification BP 2019 b. Assay GC 79. Probenecid tablets a. Identification BP 2019 b. Assay UV Spectrophotometry c. Disintegration 80. Procainamide tablets a. Identification BP 2019 b. Assay Titrimetry
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 19 of 50
MATERIALS / PRODUCTS TESTED TESTS / PROPERTIES STANDARD METHODS /
TECHNIQUES / EQUIPMENT
81. Prochlorperazine tablets a. Identification BP 2019 b. Assay UV Spectrophotometry c. Related substances TLC 82. Proguanil tablets a. Identification BP 2019 b. Assay HPLC 83. Promazine tablets a. Identification BP 2019 b. Assay UV Spectrophotometry 84. Promethazine hydrochloride a. Identification BP 2019 tablets b. Assay UV Spectrophotometry 85. Propranolol hydrochloride tablets a. Identification BP 2019 b. Assay UV Spectrophotometry 86. Propylthiouracil tablets a. Identification BP 2019 b. Assay Titrimetry 87. Pseudoephedrine hydrochloride a. Identification USP42-NF37 tablets b. Assay HPLC 88. Pyridostigmine tablets a. Identification BP 2019 b. Assay UV Spectrophotometry 89. Quinine sulfate tablets a. Identification BP 2019 b. Assay Titrimetry 90. Ranitidine tablets a. Identification BP 2019 b. Assay HPLC 91. Salbutamol tablets a. Identification BP 2019 b. Assay HPLC 92. Sodium chloride tablets a. Identification BP 2019 b. Assay Titrimetry 93. Spironolactone tablets a. Identification BP 2019 b. Assay UV Spectrophotometry c. Dissolution UV Spectrophotometry 94. Stilboestrol tablets a. Identification BP 2019 b. Assay UV Spectrophotometry
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 20 of 50
MATERIALS / PRODUCTS TESTED TESTS / PROPERTIES STANDARD METHODS /
TECHNIQUES / EQUIPMENT
95. Sulfamethoxazole and a. Identification USP42-NF37 Trimethoprim tablets b. Assay HPLC 96. Sulfasalazine tablets a. Identification USP42-NF37 b. Assay UV Spectrophotometry 97. Sulindac tablets a. Identification BP 2019 b. Assay UV Spectrophotometry 98. Tamoxifen tablets a. Identification BP 2019 b. Assay UV Spectrophotometry 99. Terbutaline tablets a. Identification BP 2019 b. Assay HPLC 100. Theophylline tablets a. Identification USP42-NF37 b. Assay HPLC c. Dissolution UV Spectrophotometry 101. Theophylline, Ephedrine a. Identification USP42-NF37 hydrochoride and Phenobarbital b. Assay HPLC tablets 102. Thiamine tablets a. Identification BP 2019 b. Assay HPLC 103. Thioridazine tablets a. Identification USP42-NF37 b. Assay HPLC 104. Levothyroxine tablets / a. Identification BP 2019 Thyroxine tablets b. Assay HPLC 105. Tolbutamide tablets a. Identification BP 2019 b. Assay Titrimetry 106. Triamterene and a. Identification USP42-NF37 Hydrochlorothiazide tablets b. Assay HPLC 107. Trifluoperazine tablets a. Identification BP 2019 b. Assay UV Spectrophotometry 108. Trimethoprim tablets a. Identification BP 2019 b. Assay UV Spectrophotometry
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 21 of 50
MATERIALS / PRODUCTS TESTED TESTS / PROPERTIES STANDARD METHODS /
TECHNIQUES / EQUIPMENT
109. Triprolidine and Pseudoephedrine a. Identification USP42-NF37 hydrochloride tablets b. Assay HPLC 110. Verapamil tablets a. Identification BP 2019 b. Assay UV Spectrophotometry 111. Warfarin tablets a. Identification BP 2019 b. Assay HPLC C. CAPSULES 1. Amoxycillin capsules a. Identification BP 2019 b. Assay HPLC 2. Ampicillin capsules a. Identification BP 2019 b. Assay HPLC 3. Cephalexin capsules a. Identification BP 2019 b. Assay HPLC 4. Chloramphenicol capsules a. Identification BP 2019 b. Assay HPLC 5. Chlordiazepoxide capsules a. Identification BP 2019 b. Assay UV Spectrophotometry (BP 2016) 6. Cloxacillin capsules a. Identification USP42-NF37 b. Assay HPLC 7. Dextropropoxyphene capsules a. Identification BP 2019 b. Assay Titrimetry 8. Diazepam capsules a. Identification USP42-NF37 b. Assay HPLC 9. Doxycycline capsules a. Identification BP 2019 b. Assay HPLC c. Loss on drying 10. Flucloxacillin capsules a. Identification BP 2019 b. Assay HPLC
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 22 of 50
MATERIALS / PRODUCTS TESTED TESTS / PROPERTIES STANDARD METHODS /
TECHNIQUES / EQUIPMENT
11. Flurazepam capsules a. Identification BP 2019 b. Assay UV Spectrophotometry 12. Gemfibrozil capsules a. Identification USP42-NF37 b. Assay HPLC 13. Hydroxyzine pamoate capsules a. Identification USP42-NF37 b. Assay HPLC 14. Indomethacin capsules a. Identification BP 2019 b. Assay UV Spectrophotometry 15. Isosorbide dinitrate extended a. Identification USP42-NF37 release capsules b. Assay HPLC 16. Ketoprofen capsules a. Identification BP 2019 b. Assay UV Spectrophotometry 17. Lincomycin hydrochloride capsules a. Assay USP42-NF37 - HPLC 18. Lithium carbonate capsules a. Identification USP42-NF37 a. Assay AAS 19. Loperamide hydrochloride a. Identification USP42-NF37 capsules b. Assay HPLC 20. Mefenamic acid capsules a. Identification BP 2019 b. Assay Titrimetry 21. Nifedipine capsules a. Identification USP42-NF37 b. Assay HPLC c. Dissolution UV Spectrophotometry d. Uniformity of dosage units UV Spectrophotometry e. Related compounds HPLC 22. Phenoxybenzamine capsules a. Identification BP 2019 b. Assay HPLC 23. Extended Phenytoin sodium a. Identification USP42-NF37 capsules b. Assay HPLC 24. Piroxicam capsules a. Identification USP42-NF37 b. Assay HPLC
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 23 of 50
MATERIALS / PRODUCTS TESTED TESTS / PROPERTIES STANDARD METHODS /
TECHNIQUES / EQUIPMENT
25. Rifampicin capsules a. Identification BP 2019 b. Assay UV Spectrophotometry c. Related substances HPLC 26. Tetracycline hydrochloride a. Identification USP42-NF37 capsules b. Assay HPLC c. Dissolution UV Spectrophotometry d. Loss on drying 27. Theophylline capsules a. Identification USP42-NF37 b. Assay HPLC
D SYRUPS, MIXTURES & ORAL SUSPENSION 1. Aluminium Hydroxide oral a. Identification BP 2019
suspension b. Assay Titrimetry
c. Neutralising capacity 2. Amoxycillin oral suspension a. Identification BP 2019
b. Assay HPLC
c. Acidity or alkalinity 3. Ampicillin oral suspension a. Identification BP 2019
b. Assay HPLC
c. Acidity and alkalinity 4. Cephalexin oral suspension a. Identification BP 2019
b. Assay HPLC
5. Chloral Hydrate oral solution a. Identification BP 2019 b. Assay Titrimetry
6. Chlorpheniramine maleate syrup a. Identification USP42-NF37
b. Assay UV Spectrophotometry
7. Chlorpromazine oral solution a. Identification BP 2019
b. Assay UV Spectrophotometry 8. Cloxacillin oral solution a. Identification USP42-NF37 b. Assay HPLC c. pH
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 24 of 50
MATERIALS / PRODUCTS TESTED TESTS / PROPERTIES STANDARD METHODS /
TECHNIQUES / EQUIPMENT
9. Codeine phosphate oral solution a. Identification BP 2019 b. Assay HPLC 10. Cyproheptadine hydrochloride a. Identification USP42-NF37 oral solution b. Assay HPLC
c. pH
11. Dexamethasone elixir a. Identification USP42-NF37 b. Assay HPLC 12. Dexchlorpheniramine maleate a. Identification USP42-NF37
syrup b. Assay UV Spectrophotometry
13. Dextromethorphan HBr syrup a. Identification USP42-NF37 b. Assay HPLC 14. Diazepam oral solution a. Identification BP 2019 b. Assay UV Spectrophotometry 15. Digoxin elixir a. Identification USP42-NF37 b. Assay HPLC 16. Dimenhydrinate syrup a. Identification USP42-NF37 b. Assay HPLC 17. Diphenhydramine hydrochloride a. Identification USP42-NF37 elixir b. Assay HPLC 18. Diphenoxylate hydroxide and a. Identification USP42-NF37 Atropine sulphate oral solution b. Assay HPLC 19. Ephedrine elixir a. Identification BP 2019 b. Assay HPLC 20. Erythromycin ethylsuccinate for a. Identification USP42-NF37 oral suspension 21. Guaifenesin syrup a. Identification USP42-NF37 b. Assay HPLC 22. Haloperidol oral solution a. Identification BP 2019 b. Assay UV Spectrophotometry 23. Hydroxyzine hydrochloride syrup a. Identification USP42-NF37 b. Assay HPLC
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 25 of 50
MATERIALS / PRODUCTS TESTED TESTS / PROPERTIES STANDARD METHODS /
TECHNIQUES / EQUIPMENT
24. Kaolin mixture a. Acid-insoluble matter BP 2019 b. Assay Titrimetry 25. Aromatic Magnesium carbonate a. Assay BP 2019 - Titrimetry mixture 26. Magnesium trisilicate mixture a. Identification BP 2019 b. Assay Titrimetry c. Neutralising capacity 27. Metoclopramide oral solution a. Identification USP42-NF37 b. Assay HPLC 28. Naproxen oral suspension a. Identification BP 2019 b. Assay UV Spectrophotometry 29. Oxtriphylline oral solution a. Identification USP42-NF37 b. Assay HPLC 30. Liquid Paraffin oral emulsion a. Assay BP 2019 - Gravimetry 31. Penicillin V potassium for oral a. Identification USP42-NF37 solution b. Assay HPLC 32. Phenobarbitone elixir a. Identification BP 2019 b. Assay HPLC 33. Pholcodine linctus a. Identification BP 2019 b. Assay Titrimetry 34. Strong Pholcodine linctus a. Identification BP 2019 b. Assay Titrimetry 35. Piperazine citrate syrup a. Identification USP42-NF37 b. Assay Gravimetry 36. Potassium citrate mixture a. Identification BP 2019 b. Assay Titrimetry 37. Prednisolone syrup a. Identification USP42-NF37 b. Assay HPLC 38. Promethazine oral solution a. Identification BP 2019 b. Assay UV Spectrophotometry c. Related substances TLC
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 26 of 50
MATERIALS / PRODUCTS TESTED TESTS / PROPERTIES STANDARD METHODS /
TECHNIQUES / EQUIPMENT
39. Pyrantel pamoate oral suspension a. Identification USP42-NF37 b. Assay HPLC 40. Sulfamethoxazole and a. Identification USP42-NF37 Trimethoprim oral suspension b. Assay HPLC 41. Theophylline and Guaifenesin a. Identification USP42-NF37 oral solution b. Assay HPLC 42. Triprolidine and Pseudoephedrine a. Identification USP42-NF37 hydrochloride syrup b. Assay HPLC 43. Triprolidine hydrochloride syrup a. Identification USP42-NF37 b. Assay HPLC
E. CREAM, OINTMENT & LOTION 1. Acyclovir cream a. Identification BP 2019 b. Assay BP 2014 – UV Spectrophotometry 2. Beclomethasone cream a. Identification BP 2019 b. Assay HPLC 3. Compound Benzoic acid ointment a. Identification BP 2019 b. Assay Titrimetry & UV
Spectrophotometry 4. Benzalkonium chloride solution a. Identification BP 2019 b. Assay Titrimetry 5. Benzoyl peroxide gel a. Identification BP 2019 b. Assay Titrimetry 6. Benzyl benzoate application a. Assay BP 2019-HPLC 7. Betamethasone cream a. Identification USP42-NF37 b. Assay HPLC 8. Betamethasone dipropionate a. Identification USP42-NF37 cream b. Assay HPLC 9. Betamethasone valeate cream a. Identification BP 2019 b. Assay HPLC
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 27 of 50
MATERIALS / PRODUCTS TESTED TESTS / PROPERTIES STANDARD METHODS /
TECHNIQUES / EQUIPMENT
10. Betamethasone valeate lotion a. Identification BP 2019 / USP42-NF37 Assay HPLC 11. Betamethasone valeate ointment a. Identification BP 2019 / USP42-NF37 b. Assay HPLC 12. Cetrimide cream a. Identification BP 2019 b. Assay Titrimetry 13. Cetrimide solution a. Identification BP 2019 b. Assay Titrimetry 14. Chloramphenicol eye ointment a. Identification BP 2019 / USP42-NF37 b. Assay HPLC 15. Chlorhexidine gluconate solution a. Identification BP 2019 b. Assay Titrimetry c. Acidity or alkalinity 16. Chlorhexidine irrigation solution a. Identification BP 2019 b. Assay HPLC c. Acidity 17. Chlortetracycline eye ointment a. Identification BP 2019 18. Choline salicylate dental gel a. Identification BP 2019 (Oromucosal gel) b. Assay Titrimetry 19. Ciprofloxacin ophthalmic solution a. Identification USP42-NF37 b. Assay HPLC 20. Clothrimazole and Betamethasone a. Identification USP42-NF37 dipropionate cream b. Assay HPLC 21. Clotrimazole cream a. Identification BP 2019 b. Assay HPLC c. 2-Chlorotritanol HPLC 22. Clotrimazole topical solution a. Identification USP42-NF37 b. Assay HPLC 23. Coal tar and salicylic ointment a. Identification BP 2019 b. Assay UV Spectrophotometry
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 28 of 50
MATERIALS / PRODUCTS TESTED TESTS / PROPERTIES STANDARD METHODS /
TECHNIQUES / EQUIPMENT
24. Dexamethasone sodium a. Identification USP42-NF37 phosphate cream b. Assay HPLC 25. Econazole cream a. Identification BP 2019 b. Assay HPLC 26. Fluocinolone cream a. Identification BP 2019 b. Assay HPLC 27. Fluocinolone acetonide ointment a. Identification USP42-NF37 b. Assay HPLC 28. Fluocinonide cream a. Identification USP42-NF37 b. Assay HPLC 29. Formaldehyde solution a. Identification BP 2019 b. Assay Titrimetry c. Acidity d. Appearance e. Methanol f. Sulphated ash 30. Gentamicin cream a. Identification BP 2019
31. Gentamicin ointment a. Identification BP 2019
32. Hydrocortisone and Neomycin a. Identification BP 2019
cream b. Assay HPLC
33. Hydrocortisone acetate cream a. Identification BP 2019
b. Assay HPLC
34. Hydrocortisone and clioquinol a. Identification BP 2019
cream b. Assay HPLC & UV Spectrophotometry
35. Hydrocortisone cream a. Identification BP 2019
b. Assay HPLC
36. Hydrogen peroxide solution (3%) a. Identification BP 2019
b. Assay Titrimetry
c. Acidity
d. Organic stabilisers
e. Non-volatile matter
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 29 of 50
MATERIALS / PRODUCTS TESTED TESTS / PROPERTIES STANDARD METHODS /
TECHNIQUES / EQUIPMENT
37. Lignocaine and Chlorhexidine gel a. Identification BP 2019
b. Assay HPLC & Titrimetry
38. Methyl salicylate liniment a. Identification BP 2019
b. Assay GC
39. Metronidazole gel a. Identification USP42-NF37
b. Assay HPLC
40. Miconazole nitrate cream a. Identification USP42-NF37
b. Assay HPLC
41. Miconazole nitrate topical powder a. Identification USP42-NF37
b. Assay GC
42. Neomycin sulfate and Bacitracin a. Identification USP42-NF37
ointment
43. Neomycin and Polymycin B and a. Identification USP42-NF37
Bacitracin ointment
44. Neomycin sulfate cream a. Identification USP42-NF37 45. Neomycin sulfate and a. Identification USP42-NF37
Dexamethasone sodium phosphate b. Assay HPLC
cream
46. Neomycin sulfate and a. Identification USP42-NF37
Dexamethasone sodium phosphate b. Assay HPLC
ointment
47. Neomycin sulfate and a. Identification USP42-NF37
Fluocinolone acetonide cream b. Assay HPLC
48. Neomycin sulfate and a. Identification USP42-NF37
Hydrocortisone acetate cream b. Assay HPLC
49. Nystatin ointment a. Identification BP 2019 50. Polymycin and Bacitracin eye a. Identification BP 2019 ointment 51. Povidone-Iodine topical solution a. Identification USP42-NF37 b. Assay Titrimetry
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 30 of 50
MATERIALS / PRODUCTS TESTED TESTS / PROPERTIES STANDARD METHODS /
TECHNIQUES / EQUIPMENT
52. Salicylic acid Collodion a. Identification BP 2019 b. Assay UV Spectrophotometry 53. Salicylic acid ointment a. Identification BP 2019 b. Assay Titrimetry 54. Selenium sulphide scalp application a. Identification BP 2019 b. Assay Titrimetry 55. Silver sulfadiazine cream a. Identification USP42-NF37 b. Assay HPLC 56. Dilute Sodium hypochlorite solution a. Assay BP 2019- Titrimetry 57. Strong Sodium hypochlorite solution a. Assay BP 2019- Titrimetry 58. Tetracycline hydrochloride ointment a. Identification USP42-NF37 b. Assay HPLC c. Water 59. Tolnaftate cream a. Identification USP42-NF37 b. Assay UV Spectrophotometry 60. Tolnaftate topical solution a. Identification USP42-NF37 b. Assay UV Spectrophotometry 61. Tretinoin gel a. Identification BP 2019 b. Assay UV Spectrophotometry 62. Tretinoin cream a. Identification USP42-NF37 b. Assay HPLC 63. Triamcinolone cream a. Identification BP 2019 b. Assay HPLC
F EYE DROPS & EAR DROPS 1. Atropine eye drops a. Identification BP 2019 b. Assay HPLC 2. Betamethasone eye drops a. Identification BP 2019 b. Assay HPLC 3. Chloramphenicol eye drops a. Identification BP 2019 b. Assay HPLC c. Acidity or Alkalinity
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 31 of 50
MATERIALS / PRODUCTS TESTED TESTS / PROPERTIES STANDARD METHODS /
TECHNIQUES / EQUIPMENT
4. Chloramphenicol ear drops a. Identification BP 2019 b. Assay HPLC 5. Cyclopentolate eye drops a. Identification BP 2019 b. Assay HPLC 6. Dexamethasone sodium phosphate a. Identification USP42-NF37 ophthalmic ointment b. Assay HPLC 7. Dexamethasone ophthalmic a. Identification USP42-NF37 suspension b. Assay HPLC 8. Dexamethasone sodium phosphate a. Identification USP42-NF37 ophthalmic solution b. Assay HPLC 9. Ephedrine nasal drops a. Identification BP 2019 b. Assay HPLC 10. Gentamicin eye drops a. Identification BP 2019 11. Hydrocortisone Acetate and a. Identification BP 2019 Neomycin eye drops b. Assay HPLC 12. Naphazoline hydrochloride a. Identification USP42-NF37 ophthalmic solution b. Assay HPLC 13. Neomycin eye drops a. Identification BP 2019 14. Neomycin sulfate and a. Identification USP42-NF37 Dexamethasone sodium phosphate b. Assay HPLC ophthalmic solution 15. Neomycin and Polymyxin B sulfates a. Identification USP42-NF37 cream 16. Prednisolone acetate ophthalmic a. Identification USP42-NF37 suspension b. Assay HPLC 17. Oxymetazoline hydrochloride nasal a. Identification USP42-NF37 solution b. Assay HPLC 18. Oxymetazoline hydrochloride a. Identification USP42-NF37 ophthalmic solution b. Assay HPLC
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 32 of 50
MATERIALS / PRODUCTS TESTED TESTS / PROPERTIES STANDARD METHODS /
TECHNIQUES / EQUIPMENT
19. Phenylephrine hydrochloride a. Identification USP42-NF37 ophthalmic solution b. Assay HPLC 20. Pilocarpine hydrochloride a. Identification USP42-NF37 ophthalmic solution b. Assay HPLC 21. Prednisolone acetate ophthalmic a. Identification USP42-NF37 suspension b. Assay HPLC 22. Sodium chloride eye lotion a. Assay BP 2019- Titrimetry 23. Sulphacetamide sodium and a. Identification USP42-NF37 Prednisolone acetate ophthalmic b. Assay HPLC suspension 24. Timolol maleate ophthalmic solution a. Identification USP42-NF37 b. Assay HPLC c. pH
G SUPPOSITORIES PESSARIES & INHALATION 1. Bisacodyl suppositories a. Identification BP 2019 b. Assay Titrimetry 2. Econazole pessaries a. Identification BP 2019 b. Assay Titrimetry 3. Indomethacin suppositories a. Identification BP 2019 b. Assay UV Spectrophotometry 4. Lactic acid pessaries a. Assay BP 2019- Titrimetry 5. Metronidazole suppositories a. Identification BP 2019 b. Assay Titrimetry 6. Naproxen suppositories a. Identification BP 2018 b. Assay HPLC 7. Beclomethasone pressurised a. Identification BP 2019 inhalation b. Assay HPLC 8. Salbutamol pressurised inhalation a. Identification BP 2019 b. Assay HPLC
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 33 of 50
MATERIALS / PRODUCTS TESTED
TESTS / PROPERTIES STANDARD METHODS /
TECHNIQUES / EQUIPMENT
H TRADITIONAL a. Copper Closed Vessel Microwave Digestion, MEDICINES & FAAS (Flame Atomic Absorption SUPPLEMENTS Spectrometry) PHARM TMA Ver-006 b. Screening for Western Drug PHARM SCHP Ver-009 Adulterants in Complementary GCMS, HPLC Health Products * * - refer to Annex I c. Determination of Aflatoxins PHARM-AFLA Ver-004 B & G d. Determination of HPLC-DAD Diphenoxylate for Drug Abuse PHARM DIPHEN Ver-003 Cases e. Identification of Common Drugs LTQ ORBITRAP XL FTMS PHARM IDHRMS Ver-003 f. Identification of Chiral Drugs HPLC-DAD PHARM DLXM Ver-003 g. Identification of Common LCMS Drugs PHARM IDLCMS Ver-002 h. Identification of Common GCMS Drugs PHARM IDGM Ver-002 i. Identification of Sildenafil, LCMSMS Tadalafil and Vardenafil PHARM IDMSMS Ver-002 I RED YEAST RICE a. Lovastatin HPLC-DAD PHARM LOVA Ver-006 J HERBAL PRODUCTS a. Determination of Aconite SPE & LCMSMS (Q-trap) Alkaloids in Herbal PHARM ACONITE Ver-007 Products b. Determination of Ephedra Liquid solvent extraction & LCMSMS Alkaloids in Herbal (Q-trap) Products PHARM EPHEDRA Ver-008 c. Determination of Berberine LC – DAD in Herbal Products PHARM BER Ver-006
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 34 of 50
MATERIALS / PRODUCTS TESTED
TESTS / PROPERTIES STANDARD METHODS /
TECHNIQUES / EQUIPMENT
d. Identification of Colchicum LCMSMS Alkaloids in Herbal PHARM COLC Ver-007 Products e. Determination of Lobeline HPLC-DAD and Lobelanidine in Herbal PHARM LOBE Ver-004 Products f. Identification of LCMSMS Cannabinoids in Herbal PHARM CNB Ver-003 Products g. Determination of Pesticides in GCMSMS/LCMSMS Herbal Products PHARM PESTMS Ver-002 h. Identification of Aristolochic LC-HRMS Acid I & II in Herbal Products PHARM AA_HRMS Ver-001 i. Identification of Aconite LC-HRMS Alkaloids in Herbal Products PHARM Aco_HRMS Ver-001 K COUGH MIXTURE a. Analysis of Codeine, HPLC-DAD / GCMS Dextromethorphan / PHARM CMMHA Ver-003 Levomethorphan, Diamorphine & Methamphetamine in Cough Mixture L HEALTH PRODUCTS a Determination of Aristolochic LCMSMS Acid I & II in Health Products PHARM AAHP Ver-004 b 4-in-1 Toxic Metals Analysis in ICPMS Complementary Health PHARM HMA Ver-003 Products c Determination of HPLC / LCMSMS Tetrahydropalmatine in Health PHARM THP Ver-002 Products d. 4-in-1 Toxic Metal Analysis ICPMS (Pb, As, Hg and Cd) in PHARM HMAUW Ver-001 Complementary Health Products Using Ultrawave Microwave Acid Digestion System
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 35 of 50
Approved Signatories S/N Name Scope
1. Ms Low Min Yong - For all accredited tests.
2. Dr Cheah Nuan Ping - For all accredited tests.
3. Ms Joyce Kiang Kin Har - For all accredited tests.
4. Dr Ge Xiaowei - For all accredited tests.
5. Dr Kee Chee Leong - For all accredited tests.
6. Ms Agnes Chin Lee Cheng - For all accredited tests.
7. Ms Low Lan Eng - For all accredited tests.
8. Dr Zeng Yun - For all accredited tests.
9. Ms Xu Yimin - For all accredited tests.
10. Dr Quek Yi Ling - For all accredited tests.
11. Dr Sun Cuilian - For all accredited tests.
Note:
This laboratory is accredited in accordance with the recognised International Standard ISO/IEC 17025. A
laboratory's fulfilment of the requirements of ISO/IEC 17025 means the laboratory meets both the technical
competence requirements and management system requirements that are necessary for it to consistently
deliver technically valid test results. The management system requirements in ISO/IEC 17025 are written
in language relevant to laboratory operations and operate generally in accordance with the principles of ISO
9001.
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 36 of 50
Annex 1
LIST OF COMMON ADULTERANTS AND TEST METHODS FOR CHINESE PROPRIETARY MEDICINES
Effect Grouping Most Possible Adulterants for CPM Test Method
Analgesics Aspirin LC Screening
Codeine GCMS Screening
Diclofenac GCMS Screening
Flurbiprofen LC Screening
Fenbufen LC Screening
Ibuprofen GCMS Screening
Indomethacin LC Screening
Ketoprofen LC Screening
Ketorolac Tromethamine LC Screening
Mefenamic Acid LC Screening
Morphine GCMS Screening
Naproxen LC Screening
Nimesulide GCMS Screening
Paracetamol GCMS Screening
Phenylbutazone GCMS Screening
Piroxicam LC Screening
Salicylamide GCMS Screening
Sulindac LC Screening
Tramadol GCMS Screening
Androgenic Steroids Danazol GCMS/LC Screening
DHEA (Dehydroisoandrosterone) GCMS Screening
Fluoxymesterone GCMS Screening
Mesterolone GCMS Screening
Methandienone GCMS Screening
Methyltestosterone GCMS Screening
Nandrolone GCMS Screening
Oxandrolone GCMS Screening
Oxymetholone LC Screening
Stanozolol LC Screening
Testosterone and its esters GCMS Screening
Trenbolone GCMS Screening
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 37 of 50
Effect Grouping Most Possible Adulterants for CPM Test Method
Anti-arrhythmics Acebutolol HCl LC Screening
Amiodarone LC Screening
Atenolol LC Screening
Betaxolol HCl LC Screening
Bisoprolol LC/DAD Screening
Metoprolol Tartrate LC Screening
Metoprolol Succinate LC Screening
Mexiletine HCl LC Screening
Labetalol LC Screening
Lignocaine GCMS Screening
Oxprenolol HCl LC Screening
Phenytoin GCMS Screening
Procainamide GCMS Screening
Propranolol HCl LC Screening
Timolol GCMS Screening
Verapamil GCMS Screening
Propafenone LC/DAD Screening
Carvedilol LC/DAD Screening
Anti-asthmatics Beclometasone LC Screening
Betamethasone GCMS Screening
Clobetasol Propionate LC Screening
Cortisone Acetate GCMS Screening
Desoximethasone LC Screening
Dexamethasone GCMS Screening
Diflucortolone-21- Pivalate LC Screening
Ephedrine GCMS Screening
Flucinolone Acetonide LC Screening
Fluocinonide LC Screening
Fluticasone Propionate LC Screening
Formoterol fumerate dihydrate LC Screening
Hydrocortisone GCMS Screening
Ketotifen Fumarate GCMS Screening
Methylprednisolone LC Screening
Mometasone Furoate LC Screening
Prednisolone GCMS Screening
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 38 of 50
Effect Grouping Most Possible Adulterants for CPM Test Method
Prednisone GCMS Screening
Salbutamol LC Screening
Terbutaline SO4 LC Screening
Theophylline GCMS Screening
Triamcinolone LC Screening
Triamcinolone Acetonide LC Screening
Clenbuterol LC/DAD Screening
Bambuterol LC/DAD Screening
Antibiotics Doxycycline LC Screening
(Inactive) Minocycline LC Screening
Tetracycline LC Screening
Antibiotics Amoxycillin LC Screening
(Internal Use) Ampicillin LC Screening
Cefaclor LC Screening
Ciprofloxacin LC Screening
Cloxacillin LC Screening
Doxycycline Hyclate LC Screening
Metronidazole GCMS Screening
Minocycline LC Screening
Ofloxacin LC Screening
Penicillin G Na/K Salt LC Screening
Penicllin V.Potassium LC Screening
Tetracycline LC Screening
Tinidazole GCMS Screening
Trimethoprim GCMS Screening
Antibiotics Metronidazole GCMS Screening
(Tropical Use) Fusidic Acid as Na Salt LC Screening
(Sodium Fusidate)
Sulfadiazine /Sulphadiazine LC Screening
Anti-clotting Agent Aspirin LC Screening
Ticlopidine GCMS Screening
Warfarin LC Screening
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 39 of 50
Effect Grouping Most Possible Adulterants for CPM Test Method
Clopidogrel GCMS Screening
Dipyridamole LC Screening
Anti-comedone Agent Salicylic acid LC Screening
Antidepressants Amitriptylline GCMS Screening
Buspirone HCl GC Screening
Clomipramine LC Screening
Fluoxetine LC Screening
Flupenthixol LC Screening
Imipramine LC Screening
Isocarboxazid GCMS Screening
Maprotiline GCMS Screening
Nortriptylline LC Screening
Tranylcypromine LC Screening
Trazodone LC Screening
Moclobemide GCMS Screening
Paroxetine LC Screening
Antidiabetics Chlorpropamide LC Screening
Glibenclamide LC Screening
Gliclazide LC Screening
Glimepiride LC Screening
Glipizide LC Screening
Metformin LC Screening
Nateglinide LC Screening
Phenformin LC Screening
Rosiglitazone Maleate LC Screening
Tolbutamide LC Screening
Acetohexamide LC/DAD Screening
Tolazamide LC/DAD Screening
Repaglinide LC/DAD Screening
Antidiarrhoeals Diphenoxylate LC Screening
Loperamide LC Screening
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 40 of 50
Effect Grouping Most Possible Adulterants for CPM Test Method
Anti-emetics Buclizine LC Screening
Clorpromazine GCMS Screening
Domperidone LC Screening
Metoclopramide LC Screening
Perphenazine LC Screening
Prochlorperazine Maleate GCMS Screening
Promethazine Theoclate GCMS Screening
Trifluoperazine GCMS Screening
Ondansetron LC/DAD Screening
Anti-epileptics Carbamazepine LC Screening
Clonazepam GCMS Screening
Diazepam GCMS Screening
Ethosuximide GCMS Screening
Phenytoin GCMS Screening
Primidone LC Screening
Antifungals (Internal Use) Fluconazole GCMS Screening
Griseofulvin GCMS Screening
Itraconazole LC Screening
Ketoconazole LC Screening
Miconazole GCMS Screening
Tinidazole GCMS Screening
Antifungals (Topical Use) Clotrimazole LC Screening
Econazole GCMS Screening
Griseofulvin GCMS Screening
Ketoconazole LC Screening
Miconazole GCMS Screening
Tioconazole GCMS Screening
Tolnaftate GCMS Screening
Isoconazole LC/DAD Screening
Anti-gout Agent Colchicine LC Screening
Probenecid LC Screening
Sulfinpyrazone (+)- LC Screening
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 41 of 50
Effect Grouping Most Possible Adulterants for CPM Test Method
Antihelmintics Albendazole LC Screening
Mebendazole LC Screening
Niclosamide LC/DAD Screening
Praziquantel GC/MS Screening
Antihistamines Antazoline HCl GCMS Screening
Brompheniramine LC Screening
Buclizine LC Screening
Carbinoxamine Maleate GCMS Screening
Cetirizine GCMS Screening
Cinnarizine GCMS Screening
Chlorpheniramine GCMS Screening
Cyclizine GCMS Screening
Cyproheptadine GCMS Screening
Dimenhydrinate GCMS Screening
Diphenhydramine GCMS Screening
Hydroxyzine GCMS Screening
Loratadine GCMS Screening
Meclozine GCMS Screening
Pheniramine GCMS Screening
Promethazine GCMS Screening
Pyrilamine Maleate (Mepyramine maleate) GCMS Screening
Terfenadine LC Screening
Tripolidine LC Screening
Trimeprazine GCMS Screening
Antihypertensives Acebutolol HCl LC Screening
Amlodipine Besilate LC Screening
Atenolol LC Screening
Betaxolol HCl LC Screening
Captopril LC Screening
Clonidine GCMS Screening
Diazoxide LC Screening
Diltiazem HCl / Desacetyl Diltiazem GCMS Screening
Doxazosin LC Screening
Enalapril GCMS Screening
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 42 of 50
Effect Grouping Most Possible Adulterants for CPM Test Method
Hydralazine LC Screening
Indapamide LC Screening
Metoprolol Tartrate LC Screening
Metoprolol Succinate LC Screening
Oxprenolol HCl LC Screening
Propranolol HCl LC Screening
Telmisartan LC Screening
Terazosin HCl LC Screening
Antihypertensives Labetalol LC Screening
Lisinopril LC Screening
Methyldopa LC Screening
Minoxidil GCMS Screening
Nicardipine LC Screening
Nifedipine GCMS Screening
Phenoxybenzamine LC Screening
Prazosin LC Screening
Reserpine LC Screening
Timolol GCMS Screening
Verapamil GCMS Screening
Felodipine GC/MS Screening
Bisoprolol LC/DAD Screening
Carvedilol LC/DAD Screening
Anti-inflammatory Agents Aspirin GCMS/LC Screening
Beclometasone LC Screening
Betamethasone GCMS Screening
Clobetasol LC Screening
Cortisone Acetate GCMS Screening
Dexamethasone GCMS Screening
Desoximethasone LC Screening
Diclofenac GCMS Screening
Diflucortolone-21-Valerate LC Screening
Fenbufen LC Screening
Fluocinolone Acetonide LC Screening
Fluocinonide LC Screening
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 43 of 50
Effect Grouping Most Possible Adulterants for CPM Test Method
Flurbiprofen LC Screening
Fluticasone Propionate LC Screening
Hydrocortisone GCMS Screening
Ibuprofen GCMS Screening
Indomethacin LC Screening
Ketoprofen LC Screening
Ketorolac Tromethamine LC Screening
Mefenamic Acid LC Screening
Methylprednisolone LC Screening
Mometasone Furoate LC Screening
Naproxen LC Screening
Nimesulde GCMS Screening
Phenylbutazone GCMS Screening
Piroxicam LC Screening
Prednisolone GCMS Screening
Prednisone GCMS Screening
Salicylamide GCMS Screening
Sulindac LC Screening
Triamcinolone LC Screening
Triamcinolone Acetonide LC Screening
Anti-muscarinics Oxybutynin Chloride GCMS Screening
Propantheline LC Screening
Trihexyphenidyl HCl GCMS Screening
Antiprotozoal / Antimalarial Amodiaquine HCl LC Screening
Choloroquine Diphosphate GCMS Screening
Emetine HCl LC Screening
Hydroxychloroquine Sulphate LC Screening
Mefloquine GCMS Screening
Proguanil LC Screening
Pyrimethamine GC/MS Screening
Sulfadoxine LC/DAD Screening
Antipsychotics Clozapine GC Screening
Droperidol LC Screening
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 44 of 50
Effect Grouping Most Possible Adulterants for CPM Test Method
Haloperidol GCMS Screening
Methotrimeprazine GCMS Screening
Perphenzine LC Screening
Thioridazine HCl GCMS Screening
Antipyretics Aspirin LC Screening
Paracetamol GCMS Screening
Diazepam GCMS Screening
Ibuprofen GCMS Screening
Antispasmodics Dicyclomine GCMS Screening
Hyoscine Butylbromide LC Screening
Hyoscine Hydrobromide LC Screening
Hyoscine Methobromide LC Screening
Papaverine GCMS Screening
Propantheline LC Screening
Clidinium GC/MS
Antithrombotic Dipyridamole LC Screening
Anti-thyroid Agent Methimazole LC/DAD
Propylthiouracil LC/DAD
Anti-ulcer Cimetidine LC Screening
Ranitidine LC Screening
Omeprazole LC Screening
Anti-virals Oseltamivir Phosphate (Tamiflu) LC Screening
Appetite Stimulant Cyproheptadine GCMS Screening
Blood Flow Enhancers Cinnarizine GCMS Screening
Pentoxyfylline GCMS Screening
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 45 of 50
Effect Grouping Most Possible Adulterants for CPM Test Method
Cardiac Inotropic Digoxin LC Screening
Digitoxin LC Screening
Dobutamine LC Screening
CNS Stimulants & Amphetamine GCMS Screening
Anorectics Caffeine GCMS Screening
Clobenzorex LC Screening
Ephedrine GCMS Screening
Fenfluramine GCMS Screening
Mazindol GCMS Screening
Methylamphetamine GCMS Screening
Methylphenidate HCl GCMS Screening
Norephedrine GCMS Screening
Phentermine GCMS Screening
Phenylpropanolamine GCMS Screening
Pseudoephedrine GCMS Screening
Sibutramine GCMS Screening
N-Desmethyl Sibutramine GC/MS Screening
Corticosteroids Beclometasone LC Screening
Clobetasol Propionate LC Screening
Cortisone Acetate GCMS Screening
Dehydroepiandrosterone (DHEA) GCMS Screening
Desoximethasone LC Screening
Dexamethasone GCMS Screening
Diflucortolone-21-Pivalate LC Screening
Fluocinolone Acetonide LC Screening
Fluocinonide LC Screening
Fluticasone Propionate LC Screening
Hydrocortisone GCMS Screening
Methylprednisolone LC Screening
Mometasone Furoate LC Screening
Prednisolone GCMS Screening
Prednisone GCMS Screening
Triamcinolone LC Screening
Triamcinolone Acetonide LC Screening
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 46 of 50
Effect Grouping Most Possible Adulterants for CPM Test Method
Cough Suppressants Codeine GCMS Screening
Dextromethorphan GCMS Screening
Morphine GCMS Screening
Noscapine LC Screening
Pholcodeine LC Screening
Diuretics Acetazolamide LC Screening
Amiloride LC Screening
Bendroflumethiazide/Bendrofluazide LC Screening
Bumetanide LC Screening
Chlorothiazide LC Screening
Clobenzorex LC Screening
Cyclopenthiazide LC Screening
Hydrochlorothiazide LC Screening
Frusemide LC Screening
Indapamide LC Screening
Metolazone LC Screening
Spironolactone LC Screening
Torsemide LC Screening
Triamterene LC Screening
DMARDS Chloroquine Diphosphate GCMS Screening
Hydroxychloroquine LC Screening
Erectogenic Agents Alprostadil LC Method (BP)
Apomorphine (Uprima) LC Screening
Pentoxyphylline (Pentoxifylline) GCMS Screening
Phentolamine Mesylate LC Screening
Sildenafil (Viagra) LC Screening
Tadalafil (Cialis) LC Screening
Vardenafil LC Screening
Yohimbine GCMS/LC Screening
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 47 of 50
Effect Grouping Most Possible Adulterants for CPM Test Method
Estrogenic Steroids Diethylstilbestrol GCMS Screening
Estradiol GCMS Screening
Estriol GCMS Screening
Estrone GCMS Screening
Ethinylestradiol GCMS Screening
Mestranol GCMS Screening
Expectorant Guaiphenesin GCMS Screening
Growth Hormones Somatrophin LC Method (EP)
Hair Growth Promoters Finasteride LC Screening
Minoxidil GCMS Screening
Hormonal Agents Ethinylestradiol GCMS Screening
Cyproterone Acetate LC/DAD Screening
HSA Loprazolam mesilate LC Screening
Hypnotics/Sedatives/Anxiolytics
Alprazolam GCMS Screening
Bromazepam GCMS Screening
Chlordiazepoxide LC Screening
Clonazepam GCMS Screening
Clorazepate Dipotassium LC Screening
Diazepam GCMS Screening
Flunitrazepam GCMS Screening
Flurazepam GCMS Screening
Lorazepam LC Screening
Lormetazepam LC Screening
Midazolam GCMS Screening
Nimetazepam GCMS Screening
Nitrazepam GCMS Screening
Nordazepam GCMS Screening
Oxazepam LC Screening
Phenobarbital GCMS Screening
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 48 of 50
Effect Grouping Most Possible Adulterants for CPM Test Method
Laxatives & Purgatives Bisacodyl GCMS Screening
Phenolphthalein GCMS Screening
Lipid Absorption Inhibitors Orlistat (Xenical) GCMS Screening
Lipid Regulating Agent Clofibrate GCMS Screening
Gemfibrozil GCMS Screening
Lovastatin GCMS Screening
Simvastatin GCMS Screening
Thyroxine LC Screening
Pravastatin LC/DAD Screening
Bezafibrate LC/DAD Screening
Fluvastatin LC/DAD Screening
Fenofibrate LC/DAD Screening
Metabolism Enhancers Theophylline GCMS Screening
Usnic Acid LC/DAD Screening
Micturating Agents Phenoxybenzamine LC Screening
Prazosin LC Screening
Terazosin LC Screening
Doxazosin LC/DAD Screening
Mucolytics Ambroxol GCMS Screening
Bromhexine GCMS Screening
N-acetylcysteine LC Method (USP)
Myometrial Relaxants Salbutamol LC Screening
Nootropics Piracetam GCMS Screening
Nasal Decongestants Ephedrine GCMS Screening
Phenylpropanolamine GCMS Screening
Pseudoephedrine GCMS Screening
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 49 of 50
Effect Grouping Most Possible Adulterants for CPM Test Method
PDE-5 inhibitor analogues Acetil acid LC/DAD Screening
Acetildenafil LC/DAD Screening
Aminotadalafil LC/DAD Screening
Carbodenafil LC/DAD Screening
Chlorpretadalafil LC/DAD Screening
Dimethylsildenafil LC/DAD Screening
Gendenafil LC/DAD Screening
Homosildenafil LC/DAD Screening
Hydroxyacetildenafil LC/DAD Screening
Hydroxyhomosildenafil LC/DAD Screening
Hydroxythiohomosildenafil LC/DAD Screening
Hydroxyvardenafil LC/DAD Screening
Imidazosagatriazinone LC/DAD Screening
N-Desethylvardenafil LC/DAD Screening
N-Desmethylacetildenafil LC/DAD Screening
N-Desmethylsildenafil LC/DAD Screening
Nor-acetildenafil LC Screening
(Desmethylacetildenafil)
Norneosildenafil LC/DAD Screening
Piperiacetildenafil LC/DAD Screening
Pseudovardenafil LC/DAD Screening
Pyrazole N-Desmethyl Sildenafil LC Screening
Sildenafil Amide LC Screening
Sildenafil Amine HCl LC Screening
Sildenafil coupled LC Screening
Sildenafil related compound LC Screening
Thiodimethylsildenafil LC/DAD Screening
Thiohomosildenafil LC/DAD Screening
Thiosildenafil LC/DAD Screening
Xanthoanthrafil LC/DAD Screening
2-(2-Ethoxyphenyl)-5-methyl-- LC Screening
7-propyl-3H-imidazo [5,1-f] [1,2,4]triazin-4-one
Certificate No. : LA-2001-0210-A Issue No. : 23 (Part 2 of 3) Date : 06 June 2019 Page : 50 of 50
Effect Grouping Most Possible Adulterants for CPM Test Method
Progestogenic Steroids Desogestrel GCMS Screening
Dydrogesterone GCMS Screening
Ethisterone GCMS Screening
Hydroxyprogesterone LC Screening
Hydroxyprogesterone 17 alpha LC Screening
Lynoestrenol GCMS Screening
Medroxyprogesterone LC Screening
Medroxyprogesterone base LC Screening
Megesterol LC Screening
Megesterol Acetate LC Screening
Norethisterone GCMS Screening
Norgestrel LC Screening
Progesterone GCMS Screening
Norgestimate LC/DAD Screening
Selective serotonin reuptake Dapoxetine HCl LC Screening
inhibitor (SSRI)
Skeletal Muscle Relaxants Baclofen LC Screening
Orphrenadrine citrate GCMS Screening
Thyroid Agents Di-iodo-thyronine LC Screening
Liothyronine LC Screening
Pheniramine GCMS Screening
Thyroid Extract LC Method (USP)
Thyroxine LC Screening
Tiratricol LC Screening
Tricyclic Anti-depressants Amitriptylline GCMS Screening
Imipramine LC Screening
Nortriptylline LC Screening
Uterine Agent Ergometrine Maleate LC Screening
Vasodilator (peripheral) Buflomedil HCl GCMS Screening